Awarded
Clostridium botulinum (Abobotulinum) Toxin Typ A 500 E. Pulver zur Herstellung einer Injektionslösung (medizinische Indikation) St
- Buyer
- PBMG eG
- Winners
- Ipsen Pharma GmbH
- Contract value
- no value published
- Bids received
- 2
- Published
- 7 May 2026
- Awarded
- 15 Dec 2025
- Contract start
- 1 Jul 2026
- Contract end
- 30 Jun 2028stated
- Region
- Hamburg (DE600)